Atorvastatin

chemokine (C-C motif) ligand 2 ; Mus musculus







10 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31071151 Heme oxygenase-1-Dependent anti-inflammatory effects of atorvastatin in zymosan-injected subcutaneous air pouch in mice. 2019 1
2 26305254 Apple Polyphenols Decrease Atherosclerosis and Hepatic Steatosis in ApoE-/- Mice through the ROS/MAPK/NF-κB Pathway. 2015 Aug 24 1
3 24816562 Atorvastatin improves plaque stability in ApoE-knockout mice by regulating chemokines and chemokine receptors. 2014 1
4 23748430 A novel mouse model of atherosclerotic plaque instability for drug testing and mechanistic/therapeutic discoveries using gene and microRNA expression profiling. 2013 Jul 19 1
5 22134386 Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin. 2012 Jan 1
6 22432744 Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation. 2012 Aug 1
7 21419111 Atorvastatin and pitavastatin protect cerebellar Purkinje cells in AD model mice and preserve the cytokines MCP-1 and TNF-α. 2011 May 4 2
8 18289605 Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice. 2008 Mar 26 1
9 17389519 Inhibition of laser-induced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice. 2007 Apr 3
10 17961438 [Atorvastatin inhibits scavenger receptor A and monocyte chemoattractant protein-1 expressions in foam cell]. 2007 Jul 4